Medical Care
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
- Mar 13, 25
- ID: 131596
- Pages: 78
- Figures: 75
- Views: 50
The global market for Psoriatic Arthritis Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Treatment Drugs.
The Psoriatic Arthritis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health
Segment by Type
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Disease-modifying Anti-rheumatic Drugs (DMARDs)
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Treatment Drugs.
The Psoriatic Arthritis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health
Segment by Type
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Disease-modifying Anti-rheumatic Drugs (DMARDs)
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.3 Corticosteroids
1.2.4 Disease-modifying Anti-rheumatic Drugs (DMARDs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Treatment Drugs Market Perspective (2020-2031)
2.2 Global Psoriatic Arthritis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriatic Arthritis Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Psoriatic Arthritis Treatment Drugs Market Dynamics
2.3.1 Psoriatic Arthritis Treatment Drugs Industry Trends
2.3.2 Psoriatic Arthritis Treatment Drugs Market Drivers
2.3.3 Psoriatic Arthritis Treatment Drugs Market Challenges
2.3.4 Psoriatic Arthritis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Psoriatic Arthritis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriatic Arthritis Treatment Drugs Revenue
3.4 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Drugs Revenue in 2024
3.5 Global Key Players of Psoriatic Arthritis Treatment Drugs Head office and Area Served
3.6 Global Key Players of Psoriatic Arthritis Treatment Drugs, Product and Application
3.7 Global Key Players of Psoriatic Arthritis Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Psoriatic Arthritis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
6.2 North America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
7.2 Europe Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
9.2 Latin America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Psoriatic Arthritis Treatment Drugs Introduction
11.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Psoriatic Arthritis Treatment Drugs Introduction
11.2.4 Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Psoriatic Arthritis Treatment Drugs Introduction
11.3.4 Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis Treatment Drugs Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Psoriatic Arthritis Treatment Drugs Introduction
11.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.5.5 Abbvie Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Psoriatic Arthritis Treatment Drugs Introduction
11.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Psoriatic Arthritis Treatment Drugs Introduction
11.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.8.5 Celgene Corporation Recent Development
11.9 Janssen
11.9.1 Janssen Company Details
11.9.2 Janssen Business Overview
11.9.3 Janssen Psoriatic Arthritis Treatment Drugs Introduction
11.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.9.5 Janssen Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Details
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Psoriatic Arthritis Treatment Drugs Introduction
11.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.10.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.3 Corticosteroids
1.2.4 Disease-modifying Anti-rheumatic Drugs (DMARDs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Treatment Drugs Market Perspective (2020-2031)
2.2 Global Psoriatic Arthritis Treatment Drugs Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriatic Arthritis Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Psoriatic Arthritis Treatment Drugs Market Dynamics
2.3.1 Psoriatic Arthritis Treatment Drugs Industry Trends
2.3.2 Psoriatic Arthritis Treatment Drugs Market Drivers
2.3.3 Psoriatic Arthritis Treatment Drugs Market Challenges
2.3.4 Psoriatic Arthritis Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Psoriatic Arthritis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriatic Arthritis Treatment Drugs Revenue
3.4 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Treatment Drugs Revenue in 2024
3.5 Global Key Players of Psoriatic Arthritis Treatment Drugs Head office and Area Served
3.6 Global Key Players of Psoriatic Arthritis Treatment Drugs, Product and Application
3.7 Global Key Players of Psoriatic Arthritis Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Treatment Drugs Breakdown Data by Type
4.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Psoriatic Arthritis Treatment Drugs Breakdown Data by Application
5.1 Global Psoriatic Arthritis Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
6.2 North America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
7.2 Europe Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
9.2 Latin America Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Psoriatic Arthritis Treatment Drugs Introduction
11.1.4 Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Psoriatic Arthritis Treatment Drugs Introduction
11.2.4 Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Psoriatic Arthritis Treatment Drugs Introduction
11.3.4 Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis Treatment Drugs Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Psoriatic Arthritis Treatment Drugs Introduction
11.5.4 Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.5.5 Abbvie Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Psoriatic Arthritis Treatment Drugs Introduction
11.6.4 Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Psoriatic Arthritis Treatment Drugs Introduction
11.8.4 Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.8.5 Celgene Corporation Recent Development
11.9 Janssen
11.9.1 Janssen Company Details
11.9.2 Janssen Business Overview
11.9.3 Janssen Psoriatic Arthritis Treatment Drugs Introduction
11.9.4 Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.9.5 Janssen Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Details
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Psoriatic Arthritis Treatment Drugs Introduction
11.10.4 Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
11.10.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-modifying Anti-rheumatic Drugs (DMARDs)
Table 5. Key Players of Others
Table 6. Global Psoriatic Arthritis Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2020-2025)
Table 10. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2026-2031)
Table 12. Psoriatic Arthritis Treatment Drugs Market Trends
Table 13. Psoriatic Arthritis Treatment Drugs Market Drivers
Table 14. Psoriatic Arthritis Treatment Drugs Market Challenges
Table 15. Psoriatic Arthritis Treatment Drugs Market Restraints
Table 16. Global Psoriatic Arthritis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players (2020-2025)
Table 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2024)
Table 19. Ranking of Global Top Psoriatic Arthritis Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Psoriatic Arthritis Treatment Drugs, Headquarters and Area Served
Table 22. Global Key Players of Psoriatic Arthritis Treatment Drugs, Product and Application
Table 23. Global Key Players of Psoriatic Arthritis Treatment Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly Company Details
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Psoriatic Arthritis Treatment Drugs Product
Table 51. Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Psoriatic Arthritis Treatment Drugs Product
Table 56. Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Psoriatic Arthritis Treatment Drugs Product
Table 61. Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Psoriatic Arthritis Treatment Drugs Product
Table 66. Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Abbvie Company Details
Table 69. Abbvie Business Overview
Table 70. Abbvie Psoriatic Arthritis Treatment Drugs Product
Table 71. Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 72. Abbvie Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Psoriatic Arthritis Treatment Drugs Product
Table 76. Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Bristol Myers Squibb Company Details
Table 79. Bristol Myers Squibb Business Overview
Table 80. Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Product
Table 81. Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 82. Bristol Myers Squibb Recent Development
Table 83. Celgene Corporation Company Details
Table 84. Celgene Corporation Business Overview
Table 85. Celgene Corporation Psoriatic Arthritis Treatment Drugs Product
Table 86. Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 87. Celgene Corporation Recent Development
Table 88. Janssen Company Details
Table 89. Janssen Business Overview
Table 90. Janssen Psoriatic Arthritis Treatment Drugs Product
Table 91. Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 92. Janssen Recent Development
Table 93. Bausch Health Company Details
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Psoriatic Arthritis Treatment Drugs Product
Table 96. Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Psoriatic Arthritis Treatment Drugs Picture
Figure 2. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriatic Arthritis Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 5. Corticosteroids Features
Figure 6. Disease-modifying Anti-rheumatic Drugs (DMARDs) Features
Figure 7. Others Features
Figure 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Psoriatic Arthritis Treatment Drugs Report Years Considered
Figure 14. Global Psoriatic Arthritis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Psoriatic Arthritis Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Psoriatic Arthritis Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players in 2024
Figure 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue in 2024
Figure 20. North America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 22. United States Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 26. Germany Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Share by Region (2020-2031)
Figure 34. China Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 57. Janssen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 58. Bausch Health Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-modifying Anti-rheumatic Drugs (DMARDs)
Table 5. Key Players of Others
Table 6. Global Psoriatic Arthritis Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2020-2025)
Table 10. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Psoriatic Arthritis Treatment Drugs Market Share by Region (2026-2031)
Table 12. Psoriatic Arthritis Treatment Drugs Market Trends
Table 13. Psoriatic Arthritis Treatment Drugs Market Drivers
Table 14. Psoriatic Arthritis Treatment Drugs Market Challenges
Table 15. Psoriatic Arthritis Treatment Drugs Market Restraints
Table 16. Global Psoriatic Arthritis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players (2020-2025)
Table 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2024)
Table 19. Ranking of Global Top Psoriatic Arthritis Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Psoriatic Arthritis Treatment Drugs, Headquarters and Area Served
Table 22. Global Key Players of Psoriatic Arthritis Treatment Drugs, Product and Application
Table 23. Global Key Players of Psoriatic Arthritis Treatment Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Psoriatic Arthritis Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Psoriatic Arthritis Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly Company Details
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Psoriatic Arthritis Treatment Drugs Product
Table 51. Eli Lilly Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Psoriatic Arthritis Treatment Drugs Product
Table 56. Roche Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Psoriatic Arthritis Treatment Drugs Product
Table 61. Merck Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Psoriatic Arthritis Treatment Drugs Product
Table 66. Novartis Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Abbvie Company Details
Table 69. Abbvie Business Overview
Table 70. Abbvie Psoriatic Arthritis Treatment Drugs Product
Table 71. Abbvie Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 72. Abbvie Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Psoriatic Arthritis Treatment Drugs Product
Table 76. Amgen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Bristol Myers Squibb Company Details
Table 79. Bristol Myers Squibb Business Overview
Table 80. Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Product
Table 81. Bristol Myers Squibb Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 82. Bristol Myers Squibb Recent Development
Table 83. Celgene Corporation Company Details
Table 84. Celgene Corporation Business Overview
Table 85. Celgene Corporation Psoriatic Arthritis Treatment Drugs Product
Table 86. Celgene Corporation Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 87. Celgene Corporation Recent Development
Table 88. Janssen Company Details
Table 89. Janssen Business Overview
Table 90. Janssen Psoriatic Arthritis Treatment Drugs Product
Table 91. Janssen Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 92. Janssen Recent Development
Table 93. Bausch Health Company Details
Table 94. Bausch Health Business Overview
Table 95. Bausch Health Psoriatic Arthritis Treatment Drugs Product
Table 96. Bausch Health Revenue in Psoriatic Arthritis Treatment Drugs Business (2020-2025) & (US$ Million)
Table 97. Bausch Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Psoriatic Arthritis Treatment Drugs Picture
Figure 2. Global Psoriatic Arthritis Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriatic Arthritis Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 5. Corticosteroids Features
Figure 6. Disease-modifying Anti-rheumatic Drugs (DMARDs) Features
Figure 7. Others Features
Figure 8. Global Psoriatic Arthritis Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Psoriatic Arthritis Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Psoriatic Arthritis Treatment Drugs Report Years Considered
Figure 14. Global Psoriatic Arthritis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Psoriatic Arthritis Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Psoriatic Arthritis Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Psoriatic Arthritis Treatment Drugs Market Share by Players in 2024
Figure 18. Global Top Psoriatic Arthritis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Treatment Drugs Revenue in 2024
Figure 20. North America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 22. United States Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 26. Germany Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Share by Region (2020-2031)
Figure 34. China Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Psoriatic Arthritis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 57. Janssen Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 58. Bausch Health Revenue Growth Rate in Psoriatic Arthritis Treatment Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232